FilingSEC EDGAR8-K
Ensysce Biosciences Files Amendment to Series C Certificate of Designation
· SEC accepted
StageAmendment Completed
Filing content
The company filed an amendment to remove the provision granting Series C preferred stockholders the option to redeem shares for cash.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…